Internal Medicine
RSSArticles
-
Omega-3 May Help Lower Blood Pressure
A research review revealed consuming about 2 or 3 grams of the fatty acid per day showed benefit.
-
Prosecution for Excessive Painkillers Tough Case to Make
A recent case may have generated a fresh conversation about medical aid in dying and physician-assisted suicide.
-
Properly Used Decision Aids Can Help Defend Malpractice Claims
Researchers recently concluded there is a high risk of EDs overlooking serious coronary artery disease in women. Using validated diagnostic tools can help alleviate this.
-
To Bolster Antibiotic Stewardship, Refine Culture Follow-Up Process
Appoint a dedicated person who sifts through culture reports, reviews old culture data, and follows up with patients. Ideally, this person would be an expert around the antibiotic spectrum who could tailor therapy to culture results.
-
Experts Urge ED Leaders to Refocus Efforts on Antimicrobial Stewardship
Early advocates of antimicrobial stewardship tended to focus on prescribing in outpatient settings. In recent years, attention has shifted toward the ED — and there are many good reasons for this shift.
-
Unusual Hepatitis Ailment Puzzles Investigators, Frontline Providers
Emergency clinicians have another novel illness to be concerned about. Investigators are uncovering a small, but growing number of unusual cases of hepatitis in young children that is putting many of these patients at risk for bad outcomes.
-
Did You See Both ECG Findings?
The ECG in the figure was obtained from an older man with new chest pain. There are two principal ECG findings on this tracing. Do you see both?
-
Oteseconazole Capsules (Vivjoa)
The FDA has approved the first drug to reduce recurrent vulvovaginal candidiasis.
-
Neurodegeneration Biomarkers in Patients with Subjective Cognitive Complaints
In individuals with subjective cognitive decline, multiple biomarkers of neurodegeneration were found to add predictive values beyond amyloid and tau biomarkers.
-
Does Amantadine Treatment Reduce Levodopa-Induced Dyskinesias?
Early treatment with amantadine may delay levodopa-induced dyskinesia onset more than treatment with other symptomatic agents.